ST
Stereotaxis, Inc.
STXS · AMEX
$1.34 +1.14% (+$0.02)
1M -2.94%
Market Cap $127.3M
P/E Ratio -
Div. Yield -
ROE 132.62%
Piotroski F-Score Weak
3/9Valuation
26 /100
Expensive P/B 7.28x
P/S 4.23x
EV/FFO N/A
Growth
34 /100
Stable Book val. growth 16.30%
Rev. growth 4.78%
FCF growth N/A
Profitability
20 /100
Weak Net margin 74.24%
Op. margin 73.02%
FCF margin 51.56%
Quality
7 /100
Poor ROE 132.62%
ROA 40.16%
Asset turnover 0.54x
Debt
89 /100
Low Current ratio 1.42x
Debt/Equity 0.30x
Net debt/EBITDA N/A
Stability
64 /100
Moderate Rev. volatility 13.24%
EPS volatility 14.41%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STXS
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
David L. Fischel
Employees
131
Headquarters
St. Louis
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report